Evidence map›Paper›PMID 42411032›Full record

ArticleACS applied materials & interfaces2026

Ultrafast Plasmonic Nanocavity Thermocycler for Direct Real-Time Reverse Transcription PCR at a Point-of-Care Level.

Hyejeong Jeong, Eunjung Jeong, Jae-Myeong Kwon, Eun-Sil Yu, Jaehyeok Park, Hamin Na, Hye-Jin Chang, Byoung-Hoon Kang, Ki Ho Song, Donggee Rho and 3 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hyejeong JeongDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Eunjung JeongSmart Healthcare Research Institute, Biomedical Engineering Research Center, Samsung Medical Center, Seoul 06351, Republic of Korea.ORCID 0000-0002-4119-4628
Jae-Myeong KwonDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Eun-Sil YuDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Jaehyeok ParkDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Hamin NaDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Hye-Jin ChangDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Byoung-Hoon KangDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Ki Ho SongOSANG Healthcare Co., Ltd., Anyang-si, Gyeonggi-do 14040, Republic of Korea.
Donggee RhoCenter for Nano Bio Development, National NanoFab Center (NNFC), Daejeon 34141, Republic of Korea.
Minhee KangSmart Healthcare Research Institute, Biomedical Engineering Research Center, Samsung Medical Center, Seoul 06351, Republic of Korea.ORCID 0000-0003-0330-7828
Tae Yeul KimDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Ki-Hun JeongDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.ORCID 0000-0003-4799-7816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid molecular diagnostics remain constrained by two fundamental bottlenecks: nucleic acid extraction and slow thermocycling, which together limit true point-of-care deployment. Here we report ultrafast plasmonic nanocavity thermocycler (PNT) for direct real-time reverse transcription PCR (DRT-qPCR) at a point-of-care level. The PNT features a plasmonic nanocavity of clustered Au, silicon dioxide (SiO

Indexed as

COVID-19Point-of-Care SystemsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2GoldHumansRapid Diagnostic TestsSensitivity and SpecificitySilicon DioxideGoldSilicon Dioxidedirect RT-qPCRphotothermal PCRplasmonic nanocavitypoint-of-care molecular diagnosticsSARS-CoV-2ultrafast thermocycling

Identifiers

PMID42411032
PMCPMC13397491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.